[go: up one dir, main page]

GB202014116D0 - Dosage regimen - Google Patents

Dosage regimen

Info

Publication number
GB202014116D0
GB202014116D0 GBGB2014116.4A GB202014116A GB202014116D0 GB 202014116 D0 GB202014116 D0 GB 202014116D0 GB 202014116 A GB202014116 A GB 202014116A GB 202014116 D0 GB202014116 D0 GB 202014116D0
Authority
GB
United Kingdom
Prior art keywords
dosage regimen
regimen
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2014116.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Intellectual Property Development Ltd
Original Assignee
GlaxoSmithKline Intellectual Property Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Intellectual Property Development Ltd filed Critical GlaxoSmithKline Intellectual Property Development Ltd
Priority to GBGB2014116.4A priority Critical patent/GB202014116D0/en
Publication of GB202014116D0 publication Critical patent/GB202014116D0/en
Ceased legal-status Critical Current

Links

GBGB2014116.4A 2020-09-08 2020-09-08 Dosage regimen Ceased GB202014116D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2014116.4A GB202014116D0 (en) 2020-09-08 2020-09-08 Dosage regimen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2014116.4A GB202014116D0 (en) 2020-09-08 2020-09-08 Dosage regimen

Publications (1)

Publication Number Publication Date
GB202014116D0 true GB202014116D0 (en) 2020-10-21

Family

ID=72841374

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2014116.4A Ceased GB202014116D0 (en) 2020-09-08 2020-09-08 Dosage regimen

Country Status (1)

Country Link
GB (1) GB202014116D0 (en)

Similar Documents

Publication Publication Date Title
GB202019601D0 (en) Single dosage shampoo
GB201713653D0 (en) Dosage regimen
IL287132A (en) Abuse-deterrent dosage forms containing esketamine
SG11202005937QA (en) G1t38 superior dosage regimes
IL308389A (en) Dosage regimens for ecubectedin
IL281968A (en) Dosage regimen for tfpi antagonists
ZA201802816B (en) Melflufen dosage regimens for cancer
PL4003293T3 (en) Pharmaceutical development
SG10201904605WA (en) Package structure
PT4340842T (en) Sotorasib dosing regimen
SMT202400165T1 (en) Dosing regimen for anti-bcma agents
CA196439S (en) Blister package
IL315178A (en) Dosage regimen
GB202006819D0 (en) Dosage regimen
GB202015771D0 (en) Dosage regimen
GB202014116D0 (en) Dosage regimen
GB202006699D0 (en) Dosage regimen
ZA201800217B (en) Novel dosage regimen tiacumicin compound
GB202319534D0 (en) Dosage regimen
GB202306662D0 (en) Dosage regimen
IL308095A (en) Dosing regimens
GB201902454D0 (en) Dosage regimen
IL266255A (en) Novel dosage regimen
CA194932S (en) Medication package
GB202112635D0 (en) Treatment regimen

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)